Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 上海凯利泰医疗科技股份有限公司（股票代码：300326.SZ）成立于2005年，是一家集医疗器械的研发、生产、销售于一体的高新技术企业。公司以微创治疗理念为核心，产品涵盖脊柱、运医、创伤、生物材料等领域，致力于为医生和患者提供一流的产品，成为医生和患者信赖的企业。 凯利泰自成立以来一直保持着高速成长，公司拥有200余项专利技术，作为首家在国内A股上市的骨科医疗器械企业，公司不断开拓国内市场，产品覆盖了国内3500多家二级以上医院。在深耕国内市场的同时，公司产品远销海外，在欧美日等发达市场实现规模化临床应用与销售，实现中国智造的高端医疗惠及全球的愿景。 历经二十多年的深厚积淀，凯利泰完成了由传统医疗器械企业向多元化高端医用耗材平台型集团的转型升级，作为国内骨科领域的领先企业，始终立志于提高中国医疗产业的基础，坚持发扬民族医疗健康产业，在守护健康的征程中，永远做冲锋在前的开拓者!
Main Business 骨科植入医疗器械的生产、研发、销售及服务
Legal Representative 王冲
Top Executives
董事长：王冲
董事：王冲,惠一微,金诗强,WEN CHEN
独立董事：朱丁敏,刘学文,刘思伟
Top 5 Shareholder
Shareholder name Nature Holding Date
涌金投资控股有限公司流通A股7.00%31/12/2025
上海欣诚意投资有限公司流通A股5.16%31/12/2025
上海凯诚君泰投资有限公司流通A股3.51%31/12/2025
郑志刚流通A股2.96%31/12/2025
刘双全流通A股2.44%31/12/2025
Company Secretary 刘庆
Solicitors 北京市金杜律师事务所
Auditors 立信会计师事务所（特殊普通合伙）
Tel No 021-50728758
Fax No 021-50728758
Website www.kineticmedinc.com.cn
Email KMC@shkmc.com.cn
Company Address
Register: 上海市张江高科技园东区瑞庆路528号23幢2楼
Office: 上海市浦东新区张江高科技园区东区瑞庆路528号23幢2楼
Listing Date 13/06/2012
Shares Capital
Shares Capital: 717,012,682
Total A Share: 717,012,682
Listed A Share: 716,717,627
Non-tradable A Share: 295,055
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.188
DPS(RMB)* ¥ 0.100
NBV Per Share(RMB)* ¥ 3.993
Market Capitalization(RMB) 4.878B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.